CollectionsBoards
IN THE NEWS

Boards

BUSINESS
January 30, 2012
ViroPharma Inc. , an Exton specialty-pharmaceutical developer, has elected Julie H. McHugh to its board. She is chief operating officer of Endo Pharmaceuticals Holdings Inc. and was chief executive officer of Nora Therapeutics Inc. McHugh also was company group chairman for Johnson & Johnson's Worldwide Virology Business Unit and president of Centocor Inc., a J&J subsidiary.     Formula Pharmaceuticals , a privately held Berwyn company founded in 2009 that develops oncology drugs, has appointed Martyn Greenacre to its board.
SPORTS
May 10, 1991 | By Bob Ford, Inquirer Staff Writer
High on the 76ers' chalkboard list of things to do tonight will be: rebound. In the second game of the series - a 112-100 loss on Monday and a game the Sixers had a chance to win - it was rebounding as much as anything that killed the Sixers. They didn't protect their defensive board, letting the Bulls slip in for 16 offensive rebounds. "Letting them get those easy shots has made their shooting percentage look a lot better than it really should have been," said assistant coach Fred Carter.
« Prev | 1 | 2 | 3 | 4 | 5 | Next »
|
|
|
|
|